VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 2164 · 117th Congress

Lower Costs, More Cures Act of 2021

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

MCR CrapoSponsor
8 cosponsors · 8 R

7 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill establishes and modifies several programs and requirements to address prescription drug prices, particularly in relation to Medicare and Medicaid.

What it does: CRS summary · Introduced in Senate · Jun 22, 2021

Lower Costs, More Cures Act of 2021

This bill establishes and modifies several programs and requirements to address prescription drug prices, particularly in relation to Medicare and Medicaid.

Among other changes, the bill

  • requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies;
  • caps annual out-of-pocket spending under the Medicare prescription drug benefit;
  • allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region;
  • establishes requirements under the Medicaid Drug Rebate Program for certain gene therapies for which prices are indexed to achieved outcomes; and
  • establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Lower Costs, More Cures Act of 2021

Latest action (Jun 22, 2021): Read twice and referred to the Committee on Finance.

Policy area: Health · Origin: Senate · Introduced: Jun 22, 2021

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.